Skip to content
2000
Volume 5, Issue 4
  • ISSN: 1874-4710
  • E-ISSN: 1874-4729

Abstract

Nanotechnology has been the last frontier in the diagnoses and treatment of many diseases, especially in oncology. The use of nanoparticles of radiopharmaceuticals may represent the future of Nuclear Medicine. In this study we developed, characterized and tested polymeric nanoparticles of FMISO (fluoromisonidazole) in a dynamic study of biodistribution. The results of the development as characterization showed that nanoparticles were well obtained with a size range of 300- 500nm and a spherical shape.

Loading

Article metrics loading...

/content/journals/crp/10.2174/1874471011205040336
2012-10-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/crp/10.2174/1874471011205040336
Loading

  • Article Type:
    Research Article
Keyword(s): Hypoxia; Nuclear Medicine; Oncology; Predictive; Radiopharmaceuticals
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test